BioCentury
ARTICLE | Clinical News

AV0113 regulatory update

July 15, 2013 7:00 AM UTC

FDA granted Orphan Drug designation to AV0113 to treat malignant glioma. The dendritic cell-based cancer immunotherapy has Orphan Drug designation in the EU to treat glioma. AV0113 is Phase II testing...